baber/WOPTO huggingface dataset:
Patent WO-2021108676-A1 (WO)
Inventor: WANG XIANGLIN
IPC: H04N19/117
Filed: 2020-11-25
Abstract: An electronic apparatus performs a method of encoding and decoding video data. The method comprises: decoding a first coding block and a second coding block that shares a common edge on a first picture, wherein decoding the first coding block and the second coding block includes reconstructing a first residual block for the first coding block and a second residual block for the second coding block; determining that the first picture has a first resolution, a first reference picture corresponding to the first coding block has a second resolution, and a second reference picture corresponding to the second coding block has a third resolution; deriving a deblocking strength (bS) value based in part on values of the first resolution, second resolution, and the third resolution; and performing in-loop filtering on the reconstructed first residual block and the reconstructed second residual block using a deblocking filter in accordance with the derived bS value.
Patent WO-2021154400-A1 (WO)
Title: Billboard for context information sharing
Inventor: O'SHEA HELENA
IPC: G06F13/38
Filed: 2020-12-10
Abstract: Embodiments relate to a billboard circuit (326) that stores context information received from various component circuits in an electronic device. The context information indicates an operating status of the corresponding component circuit, system or shared resources. The stored context information may be retrieved by one or more component circuits when events (e.g., turning on of a component circuit) are detected. By using the billboard circuit, a component circuit may detect changes in the operating status of other components circuits and configure or update its operations even when the changes occurred while the component circuit was asleep or disabled. The billboard circuit may monitor updating of the context information by the component circuit and initiate notification to other components circuits when certain entries of the context information is updated.
Patent WO-2021127586-A1 (WO)
Title: Protein tyrosine phosphatase degraders and methods of use thereof
Inventor: VEITS GESINE KERSTIN
IPC: A61K31/454
Filed: 2020-12-18
Abstract: Provided herein are compounds, compositions, and methods useful for degrading protein tyrosine phosphatase, e.g., protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g., a cancer 5 or a metabolic disease.
Patent WO-2022139782-A1 (WO)
Title: Radar d'imagerie de pointe
Inventor: AMADJIKPE ARNAUD
IPC: H03M1/66
Filed: 2020-12-21
Abstract: Un dispositif radar peut comprendre un étage convertisseur numérique-analogique (CNA). L'étage CNA peut générer une pluralité de signaux analogiques. L'étage CNA peut générer un signal analogique différent pour chaque chaîne d'émission d'une pluralité de chaînes d'émission. Chaque signal analogique de la pluralité de signaux analogiques peut représenter un seul signal numérique. Chaque chaîne d'émission de la pluralité de chaînes d'émission peut comprendre une partie chaîne d'émission et un réseau analogique commuté de mise en forme de faisceau (BEN). La partie chaîne d'émission peut générer une pluralité de signaux analogiques intermédiaires représentatifs du signal analogique correspondant. Le réseau analogique commuté BEN peut générer une pluralité de signaux d'émission analogiques pour un signal analogique intermédiaire de la pluralité de signaux analogiques intermédiaires. La pluralité de signaux d'émission analogiques peut comprendre un faisceau mis en forme conformément à un état du réseau analogique commuté BEN.
Patent WO-2022146418-A1 (WO)
Title: Procédé, système et support lisible par ordinateur pour fournir des résultats de recherche avec des métadonnées visuellement vérifiables
Inventor: BREWINGTON BRIAN
IPC: G01C21/36
Filed: 2020-12-29
Abstract: La technologie concerne la fourniture de métadonnées visuellement vérifiables en réponse à une interrogation. Une interrogation peut être envoyée à partir d'une application. En réponse à l'interrogation, des métadonnées visuellement vérifiables correspondant à un ou plusieurs points d'intérêt pertinents pour l'interrogation et une image associée aux métadonnées visuellement vérifiables peuvent être reçues. L'image associée aux métadonnées visuellement vérifiables peut être affichée et les métadonnées visuellement vérifiables peuvent être annotées à l'intérieur de l'image affichée.
Patent WO-2021154459-A1 (WO)
Title: Systems and methods for synthesizing data for training statistical models on different imaging modalities including polarized images
Inventor: VENKATARAMAN KARTIK
IPC: G06T15/00
Filed: 2021-01-04
Abstract: A method of generating synthetic images of virtual scenes includes: placing, by a synthetic data generator implemented by a processor and memory, three- dimensional (3-D) models of objects in a 3-D virtual scene; adding, by the synthetic data generator, lighting to the 3-D virtual scene, the lighting including one or more illumination sources; applying, by the synthetic data generator, imaging modality- specific materials to the 3-D models of objects in the 3-D virtual scene in accordance with a selected multimodal imaging modality, each of the imaging modality-specific materials including an empirical model; setting a scene background in accordance with the selected multimodal imaging modality; and rendering, by the synthetic data generator, a two-dimensional image of the 3-D virtual scene based on the selected multimodal imaging modality to generate a synthetic image in accordance with the selected multimodal imaging modality.
Patent WO-2021150606-A1 (WO)
Title: Zone validation test method for a fire suppression device
Inventor: GREEN BRIAN
IPC: A62C37/36
Filed: 2021-01-20
Abstract: A zone validation test method includes disposing a fire suppression device to be certified in a testing enclosure to monitor a plurality of fire suppression zones. The fire suppression device can include a plurality of fluid distribution nozzles disposed in a first location of the testing enclosure. The fire suppression device can also include an active sensing device configured to locate a fire in the plurality of fire suppression zones. The zone validation test method can include disposing and igniting a flammable material in a test fire suppression zone within a boundary area of the test fire suppression zone. The method can further include certifying the fire suppression device by verifying that the fluid distribution nozzle corresponding to the test fire protection zone and a fluid distribution nozzle corresponding to a fire protection zone adjacent to the boundary zone area discharge fire suppression fluid.
Patent WO-2021178395-A1 (WO)
Inventor: ICHIM THOMAS
IPC: A61K35/28
Filed: 2021-03-02
Abstract: Disclosed herein, in certain embodiments, are methods and compositions for treatment of acute respiratory distress syndrome (ARDS) induced by,  inter alia , viral agents, comprising administration of fibroblasts, and/or fibroblast derivatives, and/or fibroblast apoptotic bodies. In one embodiment, a patient infected with coronavirus (COVID19) ARDS is administered a concentration of fibroblasts, intravenously, ranging from 10,000 fibroblasts to 300 million fibroblasts, based on patient characteristics and cause of ARDS. In some embodiments, fibroblasts are administered in a non-activated form, whereas in other embodiments, fibroblasts are treated under conditions stimulating enhanced activities beneficial to treatment of ARDS.
Patent WO-2021195502-A1 (WO)
Title: Polymères ramifiés à longue chaîne à base d'éthylène
Inventor: FROESE ROBERT D J
IPC: C08F210/18
Filed: 2021-03-26
Abstract: L'invention concerne des polymères à base d'éthylène qui comprennent une fraction de polymère de masse moléculaire basse et une fraction de polymère de masse moléculaire élevée, qui sont divisées par Smax sur une courbe de distribution de masse moléculaire (MWD) déterminée par chromatographie par perméation de gel absolue. La fraction de polymère de masse moléculaire basse et la fraction de polymère de masse moléculaire élevée comprennent un caractère d'échelle, L, défini pour une masse moléculaire absolue donnée (MW) en tant qu'ajustement du log de la viscosité intrinsèque [h] par rapport au log de la courbe de MW absolue (M) à l'aide de l'expression, log[η] = log(β) + αlog(M) - L*αlog (2) conformément à une courbe de Mark-Houwink-Sakurada, dans laquelle log(β) représente l'ordonnée à l'origine et α représente la pente. La fraction de polymère de masse moléculaire basse présente une MW inférieure à Smax et toutes les valeurs de L entre -0,35 et 0,35 ; et la fraction de polymère de masse moléculaire élevée présente une MW supérieure à Smax et une valeur maximale de L entre 0,8 et 1,5.
Patent WO-2021236238-A1 (WO)
Title: Système pour minimiser le risque de transmission d'une infection
Inventor: ORRINGTON JAMES
IPC: A61G10/00
Filed: 2021-04-02
Abstract: L'invention concerne des systèmes pour minimiser le risque de transmission de SARS-CoV-2 et/ou d'autres maladies infectieuses entre individus à proximité immédiate les uns des autres. Lesdits systèmes peuvent comprendre un composant de protection sensiblement transparent, un composant de chambre et un composant d'aspiration. Les systèmes de la présente invention sont destinés à éliminer tout virus du SARS-CoV-2 et/ou d'autres agents infectieux qui peuvent se déplacer à l'intérieur des aérosols.
Patent WO-2021211319-A1 (WO)
Title: Calculation of downlink positioning reference signal (prs) symbol duration for prs buffering purposes
Inventor: MANOLAKOS ALEXANDROS
IPC: H04W64/00
Filed: 2021-04-05
Abstract: Disclosed are techniques for wireless communication. In an aspect, a user equipment (UE) receives at least one positioning reference signal (PRS) resource from a reference transmission-reception point (TRP) and one or more neighboring TRPs, and processes the at least one PRS resource during a time window, wherein a length of the time window is less than or equal to an integer number of orthogonal frequency division multiplexing (OFDM) symbols of the at least one PRS resource that the UE is capable of processing, buffering, or both within the time window.
Patent WO-2021207507-A1 (WO)
Title: Shutdown mode for bandgap reference to reduce turn-on time
Inventor: LIANG BANG
IPC: H03K19/00
Filed: 2021-04-08
Abstract: Examples of the disclosure include a controller having a mode of operation including one of an on mode and an off mode, the controller including a voltage rail node, a reference node, at least one powered component configured to generate a bandgap voltage signal based on a rail voltage at the voltage rail node, a switching device coupled in series between the reference node and the at least one powered component and configured to provide a conductive path through the at least one powered component from the voltage rail node to the reference node in response to the controller being in the on mode, and to interrupt the conductive path through the at least one powered component in response to the controller being in the off mode.
Patent WO-2021221907-A1 (WO)
Inventor: SHERWINTER DANNY
IPC: A61B17/06
Filed: 2021-04-14
Abstract: Techniques are described for closure of a defect in material, such as closure of a laparoscopic surgical defect. A defect closure device can be inserted into the defect to capture first material adjacent to the defect. The device houses at least first and second suture pins coupled together by a suture. A first interaction with a trigger structure can force the first suture pin through the captured first material and into a containment sub-assembly. After rotating the device to capture second material adjacent to the defect, a second interaction with the trigger structure can force the second suture pin through the captured second material and into the containment sub-assembly. As such, the suture is passed through the first and second portions of the material, and the ends of the suture can be cinched, and cut to form a stitch.
Patent WO-2021216861-A1 (WO)
Inventor: PEREZ JUAN CARLOS FLORES
IPC: C09K8/62
Filed: 2021-04-22
Abstract: A system for diverting fluid in a borehole string includes an object configured to be deployed in the borehole string. The borehole string includes a plurality of fluid ports defining a plurality of zones along a length of the borehole string, each fluid port extending from a fluid conduit in the borehole string to at least one of: an annular region of the borehole string and a subterranean region. The object is configured to be advanced by a fluid to a fluid port to obstruct the fluid port and divert the fluid in the borehole string to another fluid port. The object includes a core portion made from a first material having a first property, and an outer portion at least partially surrounding the core portion and made from a second material, the second material being deformable and having a second property that is different than the first property.
Patent WO-2021226006-A1 (WO)
Title: Methods and systems for providing a personalized user interface
Inventor: TSAI YU-CHENG
IPC: G06Q30/02
Filed: 2021-05-04
Abstract: A computer-implemented method for providing a personalized user interface to a user may include obtaining customer data; obtaining customer article data; obtaining customer interface activity data of the at least one customer; training a prediction model; obtaining at least one of user data, user article data, or user interface activity data of a user of the apparel subscription application; determining a rank of one or more articles based on the prediction model; obtaining environmental data including values of one or more environmental factors associated with user article data; and providing, to the user, the personalized user interface associated with the apparel subscription application to the user based on the rank of the one or more articles and the environmental data.
Patent WO-2021231570-A1 (WO)
Title: Cysteamine for the treatment of sars-cov-2 infection
Inventor: THOENE JESS
IPC: A61K31/4196
Filed: 2021-05-12
Abstract: Provided herein are methods for the treatment and prevention of viral infections (e.g., coronavirus infections (e.g., severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), etc.), etc.) and diseases (e.g., Coronavirus disease 2019 (COVID-19)) associated therewith by the administration of cysteamine or derivatives thereof to a subject.
Patent WO-2021231984-A1 (WO)
Title: Obstacle monitoring systems and methods for same
Inventor: KOCER JARED ERNEST
IPC: B64C39/02
Filed: 2021-05-14
Abstract: An autonomous obstacle monitoring and vehicle control system includes a remote sensing device including one or more sensors. The remote sensing device is movable relative to an agricultural system, and configured to observe obstacles proximate to a path of an agricultural system or proximate to the agricultural system. An obstacle recognition module communicates with the remote sensing device, and is configured to identify and index obstacles proximate to the path or proximate to the agricultural system. An autonomous agricultural system controller is configured for communication with the agricultural system. The autonomous agricultural system controller includes a mission administration module configured to operate the remote sensing device, and a vehicle operation module configured to control the agricultural system based on the identified and indexed obstacles.
Patent WO-2021247475-A1 (WO)
Inventor: GRINSTAFF MARK W
IPC: C12N15/53
Filed: 2021-06-01
Abstract: Provided herein is a method to produce relaxin or relaxin analogues or variants and their use in methods of treatment, e.g., in the treatment of a stiffened fibrotic joint.
Patent WO-2021252863-A1 (WO)
Inventor: GAGNON KEVIN JAMES
IPC: C07D403/12
Filed: 2021-06-11
Abstract: L'invention concerne de nouvelles formes à l'état solide du composé I choisi parmi la forme solvate d'éthanol A, la forme B de solvate d'éthanol, la forme cristalline A, et la forme B, des compositions les comprenant, et des procédés de fabrication et d'utilisation de celles-ci, comprenant l'utilisation dans le traitement d'une maladie rénale médiée par APOL1. (I).
Patent WO-2022010936-A1 (WO)
Title: Reusable biopsy device and related systems and methods
Inventor: BIRCHER WALTER GOTTLIEB
IPC: A61B10/02
Filed: 2021-07-06
Abstract: Reusable core needle biopsy devices having an energy storage and firing mechanism comprising one or more flexure components and a disposable biopsy needle. The energy storage and firing mechanism and the biopsy needle can move between a retracted (or tensioned) position and an extended position such that a user can retract device and then actuate it to drive the needle into the target tissue.
Patent WO-2022026191-A1 (WO)
Inventor: MOFFATT STEPHEN
IPC: H01L21/67
Filed: 2021-07-14
Abstract: Embodiments disclosed herein include a semiconductor manufacturing tool with a hybrid model and methods of using the hybrid model for processing wafers and/or developing process recipes. In an embodiment, a method for developing a semiconductor manufacturing process recipe comprises selecting one or more device outcomes, and querying a hybrid model to obtain a process recipe recommendation suitable for obtaining the device outcomes. In an embodiment, the hybrid process model comprises a statistical model and a physical model. In an embodiment, the method may further comprise executing a design of experiment (DoE) on a set of wafers to validate the process recipe recommended by the hybrid process model.
Patent WO-2022016013-A1 (WO)
Title: Injectable drug-releasing microporous annealed particle scaffolds for treating myocardial infarction
Inventor: FANG JUN
IPC: A61L27/58
Filed: 2021-07-15
Abstract: A therapeutic microporous hydrogel scaffold for use in an animal is disclosed that releases one or more therapeutic agents or drugs. The scaffold uses a drug-releasing microporous annealed particle system that encapsulates drug-loaded nanoparticles into particle building blocks. By modulating nanoparticle hydrophilicity and pre-gel solution viscosity, the particle building blocks were generated with consistent and homogeneous encapsulation of nanoparticles. The scaffold may be used to treat myocardial infarction (MI) using, for example, the drugs forskolin (F) and Repsox (R). The intramyocardial injection of the pre-annealed hydrogel slurry of particles that formed the resultant scaffold improved left ventricular functions, which were further enhanced with increased angiogenesis and reduced fibrosis and inflammatory response. This therapeutic microporous hydrogel scaffold platform represents a new generation of microgel particles for MI therapy and will have broad applications in regenerative medicine and disease therapy.
Patent WO-2022020463-A1 (WO)
Title: Mesh network of reconfigurable robots
Inventor: BOUCHARD TYLER M
IPC: G05B19/4155
Filed: 2021-07-21
Abstract: A mesh network controller for a plurality of collaborative utility robots disposed around an industrial environment monitors and controls the utility robots for movement and redeployment around the industrial environment for engaging with industrial processes and receiving a process specific control program or instruction set for performing a utilization task required by the industrial process and gathering analytics from attached sensors. Upon completion or demand, the engaged utility robot may be reconfigured for receiving a different process specific instruction set for performing and data gathering of a different utilization task.
Patent WO-2022177599-A1 (WO)
Inventor: NOEL THOMAS
IPC: G06N10/00
Filed: 2021-07-29
Abstract: A trap for quantum particles,  e.g. , cesium atoms, is formed using electromagnetic radiation (EMR) of different wavelengths (concurrently and/or at different times). "Red-detuned" EMR, having a trap wavelength longer than a resonant wavelength for a quantum particle is "attracting" and, so, can be used to form the array trap while loading atoms into the array trap. "Blue-detuned" EMR, having a trap wavelength shorter than the resonant wavelength can repel atoms into dark areas away from the EMR peaks so that the atoms are not disturbed by interference carried by the EMR; accordingly, the blue-detuned EMR is used to form the array trap during quantum-circuit execution. Red and blue detuned EMR are used together to form deeper traps that can be used to detect vacant atom sites. Other combinations of trap wavelengths can also be used.
Patent WO-2022035742-A1 (WO)
Title: Metabolism-based chimeric antigen receptors and methods of treatment
Inventor: ACHARYA ABHINAV
IPC: C07K16/30
Filed: 2021-08-09
Abstract: Disclosed are compositions comprising chimeric antigen receptors (CARs) and related methods of use in cancer immunotherapy. Compositions include reprogrammed immune cells (e.g., macrophages, neutrophils, dendritic cells, and T cells) that are metabolically fit for tumor microenvironments. The engineered immune cells are reprogrammed to express one or more of recombinant CARs at their cell surfaces and are loaded with glycolysis accelerating metabolites (e.g., F16BP or succinate). Methods of treating a subject with a condition, such as cancer, are also disclosed and include administering an effective amount of a composition comprising an engineered immune cell to a subject in need thereof.
Patent WO-2022036171-A1 (WO)
Inventor: CHEN YI
IPC: A61K31/4985
Filed: 2021-08-13
Abstract: L'invention concerne des compositions de comprimés pharmaceutiques comprenant un acide organique (tel que l'acide fumarique) et un composé de Formule (I), ou un N-oxyde de celui-ci, un solvate, un polymorphe, un tautomère, un stéréoisomère, une forme isotopique ou un promédicament dudit composé de formule (I) ou un N-oxyde de celui-ci ; le composé de formule (I) étant un inhibiteur de la tyrosine kinase de Bruton.
Patent WO-2022040490-A1 (WO)
Title: Mechanical detachment system for transcatheter devices
Inventor: LE LE
IPC: A61L31/02
Filed: 2021-08-20
Abstract: This disclosure describes mechanical release systems for implantable medical devices. An embodiment includes a system comprising: a medical implant including a channel, a first aperture, and a second aperture that is located in a sidewall of the medical implant; a first wire, a second wire, a third wire, and a shaft or wire that couples the first wire to the third wire; a coil that includes the first wire but not the second wire; a first conduit: (a) releasably coupled to the medical implant, and (b) including the first wire and the second wire but not the coil; a second conduit: (a) releasably coupled to the medical implant, and (b) including the first wire, the second wire, and the coil; wherein: the first wire is: (a) included within the channel, and (b) traverses the first aperture but not the second aperture; the second wire is: (a) included within the channel, and (b) traverses the first and second apertures.
Patent WO-2022066845-A1 (WO)
Inventor: TABOR AARON
IPC: A61K35/12
Filed: 2021-09-23
Abstract: The present invention provides methods for co-administration of individual or combinations of monocistronic and / or bicistronic / multicistronic non-viral (including, but not limited to living cells and phages) and / or viral vectors and / or nucleic acids and / or any nucleic acid (modified or unmodified) effector or non-effector of cells, extracellular matrix (ECM) or biological tissue (collectively "vectors"), with any drug and / or non-drug combination (including, but not limited to aesthetic injectables), in or on the mammal for any aesthetic change or scar aesthetic improvement purpose.